Probing mucin interaction behavior of magnetic nanoparticles

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Magnetic nanoparticles (MNPs) offer potential for targeted drug delivery.
• Mucoadhesion is crucial for effective mucosal drug delivery systems.
• Developing functionalized MNPs can enhance interaction with biological barriers like mucin.

Purpose of the Study:

• To develop and characterize various iron oxide magnetic nanoparticle (MNP) formulations for mucosal delivery.
• To investigate the interaction, binding, and transport of these MNPs with porcine stomach mucin.
• To evaluate the safety and efficacy of functionalized MNPs for potential mucoadhesive drug delivery applications.

Main Methods:

• Synthesis of four MNP formulations: plain, MNPs+β-CD, MNPs+F-127, and MNPs+β-CD-F-127.
• Steady-state fluorescence spectroscopy and absorption studies to analyze MNP-mucin interactions.
• In vitro toxicity assays using cervical cancer cells and red blood cells.
• Ex vivo studies on pig gastrointestinal, ovarian, pancreas, and colon tissues.
• Boyden's chamber assay for MNP transport through mucin.

Main Results:

• The MNPs+β-CD-F-127 formulation exhibited significantly stronger interaction and binding with porcine stomach mucin compared to other formulations.
• Ex vivo studies confirmed binding and uptake of MNPs in various organ tissues.
• Transport studies demonstrated that MNPs+β-CD-F-127 could be transported through mucin.
• Toxicity assessments indicated the safety of the developed MNPs against tested cell lines and red blood cells.

Conclusions:

• The dual-functionalized MNPs (MNPs+β-CD-F-127) show superior mucoadhesive properties and transport capability.
• This formulation holds promise as an effective mucoadhesive biopharmaceutical and drug delivery system for mucosal applications.
• Further research into MNPs+β-CD-F-127 could lead to advanced drug delivery strategies.